Fasting also enhances the effectiveness of tyrosine kinase inhibitors (TKIs), a therapy commonly utilized in several types of cancer, by inhibiting mitogen-activated protein kinase (MAPK) signaling pathways and inhibit cancer cell growth(Fig. 2b) [80]. The gene discussed is WNK2; the disease is cancer.